[Immunity in patients with malignant ovarian neoplasms]. 1981

J Markowska, and T Tomaszkiewicz, and S Simm, and S Jankowiak

UI MeSH Term Description Entries
D006968 Hypersensitivity, Delayed An increased reactivity to specific antigens mediated not by antibodies but by sensitized T CELLS. Hypersensitivity, Tuberculin-Type,Hypersensitivity, Type IV,Tuberculin-Type Hypersensitivity,Type IV Hypersensitivity,Delayed Hypersensitivity,Delayed Hypersensitivities,Hypersensitivity, Tuberculin Type,Tuberculin Type Hypersensitivity,Tuberculin-Type Hypersensitivities,Type IV Hypersensitivities
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012397 Rosette Formation The in vitro formation of clusters consisting of a cell (usually a lymphocyte) surrounded by antigenic cells or antigen-bearing particles (usually erythrocytes, which may or may not be coated with antibody or antibody and complement). The rosette-forming cell may be an antibody-forming cell, a memory cell, a T-cell, a cell bearing surface cytophilic antibodies, or a monocyte possessing Fc receptors. Rosette formation can be used to identify specific populations of these cells. Immunocytoadherence,Formation, Rosette,Formations, Rosette,Immunocytoadherences,Rosette Formations
D012882 Skin Tests Epicutaneous or intradermal application of a sensitizer for demonstration of either delayed or immediate hypersensitivity. Used in diagnosis of hypersensitivity or as a test for cellular immunity. Skin Test,Test, Skin,Tests, Skin
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte

Related Publications

J Markowska, and T Tomaszkiewicz, and S Simm, and S Jankowiak
January 1969, Voprosy onkologii,
J Markowska, and T Tomaszkiewicz, and S Simm, and S Jankowiak
June 1997, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics,
J Markowska, and T Tomaszkiewicz, and S Simm, and S Jankowiak
January 1979, Archivio per le scienze mediche,
J Markowska, and T Tomaszkiewicz, and S Simm, and S Jankowiak
June 1972, Das Deutsche Gesundheitswesen,
J Markowska, and T Tomaszkiewicz, and S Simm, and S Jankowiak
November 1982, Archives of pathology & laboratory medicine,
J Markowska, and T Tomaszkiewicz, and S Simm, and S Jankowiak
May 2004, American journal of obstetrics and gynecology,
J Markowska, and T Tomaszkiewicz, and S Simm, and S Jankowiak
November 1992, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society,
J Markowska, and T Tomaszkiewicz, and S Simm, and S Jankowiak
February 1978, Tumori,
J Markowska, and T Tomaszkiewicz, and S Simm, and S Jankowiak
April 1985, Ginekologia polska,
J Markowska, and T Tomaszkiewicz, and S Simm, and S Jankowiak
June 1970, Zentralblatt fur Gynakologie,
Copied contents to your clipboard!